Revolution Medicines Inc (RVMD)
38.24
-0.61
(-1.57%)
USD |
NASDAQ |
May 08, 15:35
Revolution Medicines Total Assets (Quarterly): 2.062B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 2.062B |
September 30, 2023 | 984.23M |
June 30, 2023 | 1.074B |
March 31, 2023 | 1.073B |
December 31, 2022 | 811.93M |
September 30, 2022 | 825.91M |
June 30, 2022 | 632.80M |
March 31, 2022 | 682.77M |
December 31, 2021 | 737.99M |
September 30, 2021 | 734.98M |
Date | Value |
---|---|
June 30, 2021 | 774.05M |
March 31, 2021 | 811.65M |
December 31, 2020 | 567.40M |
September 30, 2020 | 595.07M |
June 30, 2020 | 453.96M |
March 31, 2020 | 454.34M |
December 31, 2019 | 220.53M |
September 30, 2019 | 234.74M |
December 31, 2018 | 170.59M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
220.53M
Minimum
Dec 2019
2.062B
Maximum
Dec 2023
762.83M
Average
736.48M
Median
Total Assets (Quarterly) Benchmarks
Cutera Inc | 355.17M |
BioSig Technologies Inc | 1.798M |
TRACON Pharmaceuticals Inc | 10.10M |
Zentalis Pharmaceuticals Inc | 551.69M |
Day One Biopharmaceuticals Inc | 326.64M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 235.51M |
Shareholders Equity (Quarterly) | 1.826B |
Current Ratio | 13.06 |